Amantullah Ansari

Title: Amantullah Ansari: Innovator in ENPP1 Inhibitors

Introduction

Amantullah Ansari is a notable inventor based in Greater Noida, India. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that target specific enzymes. His work focuses on addressing medical conditions associated with the dysfunction of ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1).

Latest Patents

Amantullah holds a patent for "Ectonucleotide pyrophosphatase-phosphodiesterase-1 (ENPP1) inhibitors and uses thereof." This invention discloses compounds that are useful in treating conditions linked to the dysfunction of the ENPP1 enzyme. Specifically, the patent details a compound of formula (J) that exhibits inhibitory activity against ENPP1. The method of treating conditions associated with the over-expression of the ENPP1 gene using this compound is also disclosed. Additionally, the patent includes information on the uses of these compounds, pharmaceutical compositions, and kits.

Career Highlights

Amantullah is currently associated with 1cbio, Inc., where he continues to innovate and develop new therapeutic solutions. His work has the potential to impact various medical fields, particularly those dealing with enzyme-related disorders.

Collaborations

He collaborates with talented individuals such as Brahmam Pujala and Shreya Sapra, contributing to a dynamic research environment that fosters innovation.

Conclusion

Amantullah Ansari is a pioneering inventor whose work on ENPP1 inhibitors showcases his commitment to advancing medical science. His contributions are poised to make a significant impact in the treatment of conditions related to enzyme dysfunction.